Search

everythinglearnresearchcommunity

for

Search:↓

Prenatal stress changes how male and female rats enjoy rewards differently, linked to sex hormones.

Genetics affect early female hair loss, severity depends on duration, and low ferritin levels not significant.

New resveratrol-related compounds show promise for treating various health issues but need more research for clinical use.

Female donor to male recipient sex mismatch and positive ACA-IgG are key risk factors for vitiligo and alopecia areata in chronic GvHD patients.

Finasteride significantly reduces hair growth in women with idiopathic hirsutism.

Teens with PCOS and a mom with PCOS have higher insulin resistance and lower adiponectin levels, which could signal early metabolic problems.

PRFM may help treat hair loss, especially in mild cases.

Spironolactone harms fish reproduction and is more potent in fish than invertebrates, needing environmental monitoring.

FGF9 controls which receptors it binds to through a process where two FGF9 molecules join, and changes in FGF9 can lead to incorrect receptor activation.

Dermal papillae cells, important for hair growth, come from multiple cell lines and can be formed by skin cells, regardless of their origin or hair cycle phase. These cells rarely divide, but their ability to shape tissue may contribute to their efficiency in inducing hair growth.

Nanotechnology improves minoxidil treatment for hair loss.

Chemotherapy can cause brain inflammation and damage, and understanding this process could help manage side effects.

Men with male pattern hair loss have different levels of certain hormones compared to men without hair loss.

Blocking IL-12/IL-23 does not help with hair loss in alopecia areata for mice or humans.

Low vitamin D receptor levels found in hair loss patients; topical vitamin D treatment suggested.

Mesenchymal stromal cells may help treat severe COVID-19, but more research is needed to confirm their effectiveness.

Some drugs can cause skin and hair color changes, often reversible when the drug is stopped.

Using systemic drugs as creams for skin conditions shows promise, but more research is needed to confirm their effectiveness and safety.

Hormonal changes during and after pregnancy can cause hair growth changes and hair loss, with treatments available for some conditions.

Minoxidil effectively treats hair loss, especially androgenetic alopecia, but needs more research for better understanding.

Korean patients with PCOS often have skin problems like acne and excess hair, with different symptoms based on their specific PCOS type.

Selenium might help with insulin resistance and cholesterol in PCOS, but more research is needed to confirm its benefits.

Changing the diagnosis criteria for PCOS might miss women at risk for related health issues.

Radiation-induced alopecia after angioembolization usually heals on its own and can look like other hair loss types, but patient history helps prevent misdiagnosis.

Vitamin D and estrogen may help protect heart and kidney health, and maintaining sufficient vitamin D levels could be especially beneficial for African Americans, postmenopausal women, and people with chronic kidney disease.

Both treatments reduced excessive hair growth in PCOS, but there was no difference in weight, hair score, hormone levels, or insulin resistance.

Greek women with classic PCOS are more likely to have metabolic syndrome and insulin resistance than those with newer PCOS types.

Flutamide, an antiandrogen, has minimal impact on female rat endocrine systems and does not significantly change their reproductive cycles.

T-cell reconstitution after thymus transplantation can cause hair whitening and loss.

Male tissue has more cell death than female tissue after ischemia, and some neurosteroids only protect female cells.